Back

HDAC inhibitors repress cardiac hypertrophy through hyperacetylation of 14-3-3 chaperones and nuclear accumulation of class II HDACs

27 May 2018 (14:30 - 14:45)
Organised by:
Congress Presentation Part of: Young Investigator Award: Basic Science and Translational Science Genetics, Epigenetics, ncRNA HFA Premium Access Heart Failure 2018

About the speaker

Photo
Mr Daniel Finke

University Hospital Heidelberg, Heidelberg (Germany)

5 More presentations in this session

Presentation thumbnail
Generation and validation of a mouse model of the phospholamban p.Arg14del mutation
Mr T. Eijgenraam (Groningen, NL)
Abstract
Presentation thumbnail
Changes in titin phosphorylation and PKG activity underlie diastolic dysfunction at the cross-bridge level in the early stages of type 2 diabetes
Doctor M. Waddingham (Suita, JP)
Abstract Slides Video
Presentation thumbnail
Myocyte BDNF generation prevents chronic post-ischemic decompensation via cardiac reinnervation: the role of beta-AR and GRK2 signals.
Doctor A. Cannavo (Napoly, IT)
Abstract Slides Video
Presentation thumbnail
Desmosomal integrity is challenged by exercise-induced strain in iPSC-derived cardiomyocytes with a novel desmoplakin mutation
Ms M. Vermeer (Groningen, NL)
Abstract
Presentation thumbnail
The myocardial infarction context dictates the phenotypic polarisation of antigen-specific CD4+T-cells and favours pro-healing responses in the wounded myocardium
Mr M. Rieckmann (Halle, DE)
Abstract

Access the full session

Session thumbnail
Young Investigator Award: Basic Science and Translational Science

The Event

Event poster

Heart Failure 2018

27 May 2018 14:30 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources